[{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 28000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 61, "title": "Chairman, CEO & President", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 6428574, "exercisedValue": 0, "unexercisedValue": 50993104}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 65, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 3007214, "exercisedValue": 0, "unexercisedValue": 1401880}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 61, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3327225, "exercisedValue": 0, "unexercisedValue": 7193319}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 57, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3174030, "exercisedValue": 0, "unexercisedValue": 4835902}, {"maxAge": 1, "name": "Dr. James E. Bradner M.D.", "age": 52, "title": "Executive Vice President of Research & Development", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 4095677, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 56, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 49, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Justin G. Claeys", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 5, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 275.83, "open": 277.52, "dayLow": 277.37, "dayHigh": 286.148, "regularMarketPreviousClose": 275.83, "regularMarketOpen": 277.52, "regularMarketDayLow": 277.37, "regularMarketDayHigh": 286.148, "dividendRate": 9.52, "dividendYield": 3.34, "exDividendDate": 1755820800, "payoutRatio": 0.7572, "fiveYearAvgDividendYield": 3.05, "beta": 0.477, "trailingPE": 23.317812, "forwardPE": 13.807935, "volume": 8625660, "regularMarketVolume": 8625660, "averageVolume": 2292387, "averageVolume10days": 2923950, "averageDailyVolume10Day": 2923950, "bid": 285.27, "ask": 285.72, "bidSize": 4, "askSize": 11, "marketCap": 153653854208, "fiftyTwoWeekLow": 253.3, "fiftyTwoWeekHigh": 339.17, "priceToSalesTrailing12Months": 4.4005456, "fiftyDayAverage": 290.718, "twoHundredDayAverage": 287.66785, "trailingAnnualDividendRate": 9.26, "trailingAnnualDividendYield": 0.033571403, "currency": "USD", "tradeable": false, "enterpriseValue": 201829859328, "profitMargins": 0.18956, "floatShares": 536994412, "sharesOutstanding": 538361851, "sharesShort": 11796977, "sharesShortPriorMonth": 12519619, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0219, "heldPercentInsiders": 0.00214, "heldPercentInstitutions": 0.84138, "shortRatio": 5.85, "shortPercentOfFloat": 0.022, "impliedSharesOutstanding": 542265984, "bookValue": 13.799, "priceToBook": 20.683384, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.92, "netIncomeToCommon": 6618999808, "trailingEps": 12.24, "forwardEps": 20.67, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 5.78, "enterpriseToEbitda": 12.499, "52WeekChange": -0.14957839, "SandP52WeekChange": 0.1653893, "lastDividendValue": 2.38, "lastDividendDate": 1755820800, "quoteType": "EQUITY", "currentPrice": 285.41, "targetHighPrice": 405.0, "targetLowPrice": 180.0, "targetMeanPrice": 311.45615, "targetMedianPrice": 310.0, "recommendationMean": 2.41935, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 8028000256, "totalCashPerShare": 14.912, "ebitda": 16147999744, "totalDebt": 56204001280, "quickRatio": 0.817, "currentRatio": 1.306, "totalRevenue": 34916999168, "debtToEquity": 756.651, "revenuePerShare": 64.962, "returnOnAssets": 0.07507, "returnOnEquity": 0.99139, "grossProfits": 24217999360, "freeCashflow": 10421999616, "operatingCashflow": 12012999680, "earningsGrowth": 0.92, "revenueGrowth": 0.094, "grossMargins": 0.69359, "ebitdaMargins": 0.46247002, "operatingMargins": 0.32727, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Amgen Inc.", "marketState": "CLOSED", "earningsTimestamp": 1754424000, "earningsTimestampStart": 1761768000, "earningsTimestampEnd": 1761768000, "earningsCallTimestampStart": 1754425800, "earningsCallTimestampEnd": 1754425800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 12.24, "epsForward": 20.67, "epsCurrentYear": 21.07976, "priceEpsCurrentYear": 13.539529, "fiftyDayAverageChange": -5.3079834, "fiftyDayAverageChangePercent": -0.018258188, "twoHundredDayAverageChange": -2.257843, "twoHundredDayAverageChangePercent": -0.007848784, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "postMarketChangePercent": 0.0140179, "postMarketPrice": 285.45, "postMarketChange": 0.0400085, "regularMarketChange": 9.58002, "corporateActions": [], "postMarketTime": 1758326390, "regularMarketTime": 1758312001, "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.47316, "regularMarketPrice": 285.41, "regularMarketDayRange": "277.37 - 286.148", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2292387, "fiftyTwoWeekLowChange": 32.11, "fiftyTwoWeekLowChangePercent": 0.12676668, "fiftyTwoWeekRange": "253.3 - 339.17", "fiftyTwoWeekHighChange": -53.76001, "fiftyTwoWeekHighChangePercent": -0.1585046, "fiftyTwoWeekChangePercent": -14.957839, "dividendDate": 1757635200, "shortName": "Amgen Inc.", "displayName": "Amgen", "trailingPegRatio": 0.9204, "__fetch_time": "2025-09-20"}]